Nirmesh Patel
Investor at Amino Collective
London, England
Overview
Work Experience
Investor
2024 - Current
Board Observer
2023
Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets.
Raised $38,000,000.00 from Human Ventures, Artis Ventures (AV), Merck Global Health Innovation Fund, The Venture Collective, LongeVC, Not Boring Capital, First Spark Ventures and Modi Ventures.
Board Member
2022
Board Advisor
2022
Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
Raised $14,515,000.00 from Iaso Ventures, Good AI Capital, CJ Investment, Merck Global Health Innovation Fund, Viking Global Investors and The Venture Collective.
Board Observer
2023
Orbillion Bio produces meat from the highest quality, heritage animals.
Raised $5,080,000.00 from At One Ventures, Earth Venture Capital, Metaplanet, Y Combinator and The Venture Collective.
Board Observer
2023
Advisor
2023
Investor
2017
Angel Investor and Advisor to multiple startups including Infinitopes, Epoch Bio, ReynKo, Techspert, One Health Company, BettaFish etc LP @ Twin Path Ventures
Principal
2021 - 2024
Backing world class founders building transformational technologies. Investments include Orbem, Concert Bio, Ruby Bio, Entheos, Pragma Bio (Board), Coding Bio (Board), Entocycle (Observer), Unnatural Products (Observer), Orbillion (Observer), Yuri, Epoch Bio, Endpoint Health, and Pangea Botanica among others.
TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.
Entrepreneur In Residence
2021 - 2023
Accelerating research out of academia and into the clinic.
Education
Doctor of Philosophy (PhD)
2013 - 2017
Master of Business Administration - MBA
2019 - 2020
Batch of S17
2017 - 2017
Accelerate
2016 - 2017
Master's degree
2011 - 2012
Bachelor's degree
2008 - 2011